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Purpose: Nodules located in the upper pole of the thyroid may carry a greater risk for malignancy 
than those in the lower pole. We conducted a study to analyze the risk of malignancy of nodules 
depending on location.
Methods: The records of patients undergoing thyroid-nodule fine-needle aspiration cytology 
(FNAC) at an academic thyroid cancer unit were prospectively collected. The nodules were 
considered benign in cases of a benign histology or cytology report, and malignant in cases of 
malignant histology. Pathological findings were analyzed based on the anatomical location of 
the nodules, which were also scored according to five ultrasonographic classification systems.
Results: Between November 1, 2015 and May 30, 2018, 832 nodules underwent FNAC, of which 
557 had a definitive diagnosis. The prevalence of malignancy was not significantly different in 
the isthmus, right, or left lobe. Among the 227 nodules that had a precise longitudinal location 
noted (from 219 patients [155 females], aged 56.2±14.0 years), malignancy was more frequent 
in the middle lobe (13.2%; odds ratio [OR], 9.74; 95% confidence interval [CI], 1.95 to 48.59). 
This figure was confirmed in multivariate analyses that took into account nodule composition 
and the Thyroid Imaging, Reporting, and Data System (TIRADS) classification. Using the American 
College of Radiologists TIRADS, the upper pole location also demonstrated a slightly significant 
association with malignancy (OR, 6.92; 95% CI, 1.02 to 46.90; P=0.047).
Conclusion: The risk of thyroid malignancy was found to be significantly higher for mid-lobar 
nodules. This observation was confirmed when suspicious ultrasonographic features were 
included in a multivariate model, suggesting that the longitudinal location in the lobe may be a 
risk factor independently of ultrasonographic appearance. 
Keywords: Thyroid Imaging, Reporting, and Data System; Thyroid nodule; Cytology; Location; 
Neoplasms
Received: September 9, 2018
Revised: November 1, 2018
Accepted: November 6, 2018
Correspondence to:
Giorgio Grani, MD, Department 
of Internal Medicine and Medical 
Specialties, Sapienza University of 
Rome, Viale del Policlinico 155, 00161, 
Rome, Italy
Tel. +39-06-49975130
Fax. +39-06-49975171
E-mail: giorgio.grani@uniroma1.it
ORIGINAL ARTICLE
This is an Open Access article distributed under the 
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/
licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in 
any medium, provided the original work is properly 
cited.
Copyright © 2018 Korean Society of 
Ultrasound in Medicine (KSUM)
How to cite this article: 
Ramundo V, Lamartina L, Falcone R, Ciotti L, 
Lomonaco C, Biffoni M, et al. Is thyroid nodule 
location associated with malignancy risk? 
Ultrasonography 2018 Nov 6 [Epub].
https://doi.org/10.14366/usg.18050
Introduction
Thyroid nodules may affect up to 65% of the general population, and this high rate is mainly due to 
the increasing detection of nodules through the routine use of ultrasonography in clinical practice [1]. 
Approximately 16 million individuals in the United States are estimated to have a palpable nodule, 
and up to 219 million are estimated to have an ultrasound-detectable nodule [2]. Ultrasonography 
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(US) is the primary tool for the initial cancer risk stratification of 
thyroid nodules and the subsequent decision of whether to order a 
fine-needle aspiration biopsy [2-4]. A diagnostic US report should 
include a description of the background thyroid parenchyma, nodule 
location, size, US features, and a survey of the cervical lymph nodes 
[5,6]. 
Various US characteristics of nodules, such as microcalcifications; 
hypoechogenicity; irregular, microlobulated, or infiltrative margins; 
and taller-than-wide shape, are all associated with greater 
malignancy risk, but no prior study has examined the risk of 
malignancy in relation to location in the upper versus lower pole 
of the thyroid, except for a poster presented at the American 
Association of Clinical Endocrinologists (AACE) 2018 Annual 
Scientific and Clinical Congress showing that nodules located in 
the upper pole of the thyroid gland may carry a greater risk for 
malignancy than those in the lower pole [7]. The aim of this study 
was to evaluate the frequency of thyroid nodules in various parts of 
the gland and to correlate the anatomical location with the risk of 
malignancy.
Materials and Methods
All records of patients who underwent fine-needle aspiration 
cytology (FNAC) for thyroid nodules at an academic referral center 
between November 1, 2015 and May 30, 2018 were prospectively 
collected. The study was approved by the Institutional Review 
Board and all patients signed an informed consent form. Neck 
US was performed by a physician with specific experience and 
training in thyroid US. The same sonographic equipment (HI VISION 
Avius, Hitachi Medical Corporation, Inc., Tokyo, Japan) with a high-
frequency linear transducer (12-18 MHz) with harmonic imaging 
was used to image the neck in both transverse and longitudinal 
views with grayscale and color Doppler imaging. During the real-
time US assessment, the site (right or left lobe) and size (transverse, 
anteroposterior, and longitudinal diameters) of the thyroid nodules 
subjected to FNAC were recorded. 
The US characteristics were evaluated and classified according to 
five US classification systems: the American College of Radiology 
(ACR) Thyroid Imaging, Reporting, and Data System (TIRADS) [8,9], 
the American Association of Clinical Endocrinologists/American 
College of Endocrinology/Associazione Medici Endocrinologi 
guidelines [4], the American Thyroid Association guidelines [3], the 
European Thyroid Association TIRADS [6], and the Korean Society 
of Thyroid Radiology TIRADS [10]. In each system, a set of US 
features defines a risk class that represents the likelihood that a 
nodule is malignant. Given the interobserver variability described 
for echogenicity [11], other suspicious features [12], and TIRADS 
classifications [13,14], the evaluation was performed jointly by two 
examiners (each with 8 years of thyroid imaging experience) after 
specific training [13]. 
Nodule cytology was classified according to the Italian Consensus 
for Thyroid Cytopathology [15]. This scheme is similar to the 
Bethesda classification system [16]. A composite reference standard 
was applied. Nodules were considered benign in cases of a benign 
histology or cytology report, and malignant in cases of malignant 
histology. Nodules with TIR1, TIR3A, and TIR3B cytology (similar to 
Bethesda I, III, and IV classes) without a final histologic diagnosis 
were excluded (Fig. 1).
Using this entire cohort, we studied the prevalence of malignancy 
according to location (isthmic, right lobe, or left lobe): these 557 
nodules constituted the cohort 1. On that basis, we previously 
conducted a study to evaluate US features, not location, and those 
results have already been published [17]. Since the precise location 
of the lesions was not the main focus of the previous study, the 
original examiner reported the longitudinal location in the gland 
(upper, middle, or inferior pole) only for a subset of nodules. 
Furthermore, nodules involving the whole lobe and isthmic nodules 
were excluded. In the present study, cytological and pathological 
findings were then analyzed and correlated with the craniocaudal 
Fig. 1. Flow chart of the study. Cohort 1 corresponds to the one 
reported in Table 1. Cohort 2 is presented in Tables 2-4. FNAB, fine-
needle aspiration biopsy. a)Nodules with TIR1, TIR3A, and TIR3B 
cytology (similar to Bethesda I, III and IV classes) without a final 
histologic diagnosis were excluded.
832 Nodules submitted to
FNAB
275 Not conclusive
diagnosisa)
557 Cohort 1
227 Cohort 2
40 Isthmus nodules 
290 Longitudinal location
not available 
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location of thyroid nodules in the gland (227 nodules that composed 
the cohort 2) (Fig. 1). 
Statistical analysis
Data were analyzed with the IBM SPSS Statistics package version 
25.0 (IBM Corp., Armonk, NY, USA) and Microsoft Office Suite. 
Descriptive data are reported as mean±standard deviation. 
Univariate and multivariate logistic regression analyses were 
performed to estimate the odds ratios (ORs) of malignancy and their 
95% confidence intervals (95% CIs).
Results
During the study period, 832 thyroid nodules underwent US-
guided FNAC, of which 557 had a definitive final diagnosis (513 
benign, 44 malignant). In our previous cohort study, we analyzed 
the malignancy rate according to location in the isthmus, right lobe, 
or left lobe, and found no differences between the 2 lobes and the 
isthmus (Table 1).
Of the nodules with a definitive final diagnosis, 227 had a precise 
longitudinal location noted within the lobes. These nodules were 
from 219 patients (64 males, 155 females), aged 56.2±14.0 years 
(range, 17 to 85 years). The mean maximum diameter of the thyroid 
nodules was 17.6±7.8 mm (range, 6.0 to 56.4 mm). The anatomical 
distribution of thyroid nodules showed a higher prevalence in the 
inferior pole (57.3%), with no differences between the two lobes, 
as shown in Table 3. Among the 12 malignant thyroid nodules, the 
classic variant of papillary thyroid cancer (PTC) was found in 10 
cases (83.3%), the follicular variant of PTC in one case (8.3%), and 
follicular thyroid cancer in one case (8.3%). 
In our study, thyroid malignancy was more frequent in the middle 
lobe (13.2%; OR, 9.74; 95% CI, 1.95 to 48.59) (Table 2). This 
figure was confirmed in multivariate analyses taking into account 
either solid composition of the nodule (Table 3) or the high-risk 
classification according to the five US classification systems (Table 4). 
The models remained separate (classifications and solid composition 
of the nodule were not included in the same model) because 
composition is an item taken into account to classify nodules in 
many of these systems. These systems differ from each other in their 
structure, interobserver variability [13,14], consistency over time [18], 
and number of suggested biopsies [17]. However, increased odds for 
malignancy were confirmed for mid-lobar nodules, after adjusting 
for high-risk classification according to all five systems (Table 4). 
Interestingly, in a multivariate analysis including location and an 
ACR score of TR5 (highly suspicious), the classification had an OR 
for malignancy of 9.19 (95% CI, 2.45 to 34.52), and an increased 
OR for malignancy was confirmed for nodules with a mid-lobar 
location (OR, 7.70; 95% CI, 1.47 to 40.38). The upper pole location 
also demonstrated a significant association with malignancy (OR, 
6.92; 95% CI, 1.02 to 46.90). 
Discussion
No previous study in the literature has examined the risk of thyroid 
malignancy according to the anatomical site of thyroid nodules, 
except for a preliminary report [7]. In our study, an analysis of 
the distribution of thyroid nodules showed a higher prevalence of 
Table 1. Pathological diagnoses according to isthmic, right, or 
left location
Location
Final diagnosis, n (%)
OR (95% CI)Benign 
(n=513)
Malignant 
(n=44)
Isthmus (n=40) 39 (97.5) 1 (2.5) 1
Right lobe (n=240) 217 (90.4) 23 (9.6) 4.13 (0.54-31.50)
Left lobe (n=277) 257 (92.8) 20 (7.2) 3.04 (0.40-23.26)
OR, odds ratio; CI, confidence interval.
Table 2. Pathological diagnoses according to thyroid nodule 
location
Location
Final diagnosis, n (%)
OR (95% CI) P-valueBenign 
(n=215)
Malignant 
(n=12)
Upper pole 
(n=44, 19.4%)
41 (93.2) 3 (6.8) 4.68 
(0.76-29.00)
0.097
Middle lobe 
(n=53, 23.3%)
46 (86.8) 7 (13.2) 9.74 
(1.95-48.59)
0.006
Inferior pole 
(n=130, 57.3%)
128 (98.5) 2 (1.5) 1 -
OR, odds ratio; CI, confidence interval.
Table 3. Univariate and multivariate analysis of the relationship 
between thyroid nodule location and malignancy
Location
Univariate OR 
(95% CI)
P-value
Multivariatea) 
OR (95% CI)
P-value
Upper pole 4.68 
(0.76-29.00)
0.097 4.53 
(0.71-29.07)
-
Middle lobe 9.74 
(1.95-48.59)
0.006 8.63 
(1.67-44.53)
0.010
Solid nodule - 9.26 
(1.94-44.31)
0.005
The multivariate model included longitudinal location and solid composition of the 
nodule.
OR, odds ratio; CI, confidence interval.
a)The multivariate model included longitudinal location and solid composition of the 
nodule.
Valeria Ramundo, et al.
4  Ultrasonography 2018 Nov 6 [Epub] e-ultrasonography.org
ORCID: Valeria Ramundo: https://orcid.org/0000-0003-2709-533X; Livia Lamartina: 
https://orcid.org/0000-0003-3640-1204; Rosa Falcone: https://orcid.org/0000-
0001-9679-4711; Laura Ciotti: https://orcid.org/0000-0002-9488-530X; Cristiano 
Lomonaco: https://orcid.org/0000-0002-2413-8122; Marco Biffoni: https://orcid.org/0000-
0002-7905-0881; Laura Giacomelli: https://orcid.org/0000-0003-3598-7522; 
Marianna Maranghi: https://orcid.org/0000-0002-3117-7488; Cosimo Durante: 
https://orcid.org/0000-0002-1791-5915; Giorgio Grani: https://orcid.org/0000-0002-
0388-1283
Conflict of Interest
No potential conflict of interest relevant to this article was reported.
Acknowledgments
The study was funded by a Research Starter Grant of the University 
of Rome, Sapienza (to GG, AR216154C9B479B2).
References
 1. Filetti S, Durante C, Torlontano M. Nonsurgical approaches to the 
management of thyroid nodules. Nat Clin Pract Endocrinol Metab 
2006;2:384-394.
 2. Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. 
The diagnosis and management of thyroid nodules: a review. JAMA 
2018;319:914-924.
 3. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, 
Nikiforov YE, et al. 2015 American Thyroid Association management 
guidelines for adult patients with thyroid nodules and differentiated 
thyroid cancer: the American Thyroid Association Guidelines Task 
Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 
2016;26:1-133.
 4. Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedus L, 
lesions in the inferior pole, with no differences between the two 
lobes. These data are consistent with the reports of other authors 
[19,20]. The possible causes of this tropism are still unknown and 
have not been systematically assessed in the literature, except 
for medullary thyroid cancer (no cases in this study), which is 
commonly located in the middle-upper portions of the lobes due 
to the normal aggregation of parafollicular C-cells [21]. However, 
no similar anatomical explanations are envisioned for papillary and 
follicular thyroid cancer. It is possible that nodules are in general 
more frequent in the inferior pole [19,20,22]; as a result, the 
relative frequency of malignant nodules in this area appears to be 
lower. Interestingly, the location of PTC has also been proposed as a 
prognostic factor, as lymph node metastasis has been reported to be 
more common in cases of mid-lobar [23] or upper pole [24] cancers.
This is a brief report reporting preliminary observations, with some 
limitations. First, the location of thyroid nodules was noted and 
reported only in a random subset of cases. Furthermore, a composite 
reference standard was used, with possible false-positive and false-
negative cases. Larger studies, specifically designed to investigate 
this issue, are needed to better investigate and confirm these data.
In conclusion, the risk of thyroid malignancy was found to be 
significantly higher for nodules located in the middle lobe. This 
observation was also confirmed when including solid composition 
and TIRADS classification as high-risk in a multivariate model, 
suggesting that a mid-lobe location (or mid-lobe and upper pole 
location for ACR TIRADS high-risk lesions) may be a risk factor 
independent of US appearance; therefore, it should be considered 
for potential inclusion in US classification systems.
Table 4. Multivariate analysis assessing malignancy risk according to thyroid nodule location, adjusting for high-risk estimation 
according to five ultrasonographic classification systems
Classification ACR TIRADS AACE ATA EU-TIRADS K-TIRADS
Upper pole  
OR (95% CI) 6.92 (1.02-46.90) 5.80 (0.91-37.03) 5.88 (0.91-38.12) 6.01 (0.94-38.59) 4.81 (0.75-30.79) 
P-value 0.047 0.063 0.063 0.059 0.097
Middle lobe  
OR (95% CI) 7.70 (1.47-40.38) 10.12 (2.00-51.16) 9.26 (1.81-47.44) 10.06 (1.99-50.86) 7.55 (1.45-39.31) 
P-value 0.016 0.005 0.008 0.005 0.016
High-risk classification 
OR (95% CI) 9.19 (2.45-34.52) 3.14 (0.92-10.74) 5.54 (1.50-20.46) 3.29 (0.96-11.31) 7.41 (1.95-28.12) 
P-value 0.001 0.068 0.01 0.059 0.003
The multivariate model included longitudinal location and high-risk status in the ultrasonographic classification systems. High-risk classification and solid composition of the 
nodule were not included in the same model, because composition is one of the items taken into account to classify nodules in some of the classification systems.
ACR, American College of Radiology; TIRADS, Thyroid Imaging, Reporting, and Data System; AACE, American Association of Clinical Endocrinologist; ATA, American Thyroid 
Association; EU-TIRADS, European TIRADS; K-TIRADS, Korean TIRADS; OR, odds ratio; CI, confidence interval.
Thyroid nodule location and malignancy risk
e-ultrasonography.org Ultrasonography 2018 Nov 6 [Epub] 5
et al. American Association of Clinical Endocrinologists, American 
College of Endocrinology, and Associazione Medici Endocrinologi 
medical guidelines for clinical practice for the diagnosis and 
management of thyroid nodules: 2016 update. Endocr Pract 
2016;22:622-639.
 5. American Institute of Ultrasound in Medicine; American College of 
Radiology; Society for Pediatric Radiology; Society of Radiologists 
in Ultrasound. AIUM practice guideline for the performance of a 
thyroid and parathyroid ultrasound examination. J Ultrasound Med 
2013;32:1319-1329.
 6. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. 
European Thyroid Association guidelines for ultrasound malignancy 
risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur 
Thyroid J 2017;6:225-237.
 7. Zhang F, Oluwo O, Castillo FB, Gangula, Castillo M, Farag F, et 
al. Thyroid nodule location on ultrasonography as a predictor 
of malignancy. Endocr Pract 2018 Nov 1 [Epub]. https://doi.
org/10.4158/EP-2018-0361.
 8. Grant EG, Tessler FN, Hoang JK, Langer JE, Beland MD, Berland LL, 
et al. Thyroid ultrasound reporting Lexicon: white paper of the ACR 
Thyroid Imaging, Reporting and Data System (TIRADS) Committee. 
J Am Coll Radiol 2015;12(12 Pt A):1272-1279.
 9. Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey 
SA, et al. ACR Thyroid Imaging, Reporting and Data System (TI-
RADS): white paper of the ACR TI-RADS Committee. J Am Coll 
Radiol 2017;14:587-595.
10. Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, et al. 
Ultrasonography diagnosis and imaging-based management 
of thyroid nodules: revised Korean Society of Thyroid Radiology 
consensus statement and recommendations. Korean J Radiol 
2016;17:370-395.
11. Grani G, D'Alessandri M, Carbotta G, Nesca A, Del Sordo 
M, Alessandrini S, et al. Grey-scale analysis improves the 
ultrasonographic evaluation of thyroid nodules. Medicine 
(Baltimore) 2015;94:e1129.
12. Grani G, Lamartina L, Ascoli V, Bosco D, Nardi F, D'Ambrosio F, 
et al. Ultrasonography scoring systems can rule out malignancy 
in cytologically indeterminate thyroid nodules. Endocrine 
2017;57:256-261.
13. Grani G, Lamartina L, Cantisani V, Maranghi M, Lucia P, Durante C. 
Interobserver agreement of various thyroid imaging reporting and 
data systems. Endocr Connect 2018;7:1-7.
14. Bae JM, Hahn SY, Shin JH, Ko EY. Inter-exam agreement and 
diagnostic performance of the Korean thyroid imaging reporting 
and data system for thyroid nodule assessment: Real-time versus 
static ultrasonography. Eur J Radiol 2018;98:14-19.
15. Nardi F, Basolo F, Crescenzi A, Fadda G, Frasoldati A, Orlandi F, et 
al. Italian consensus for the classification and reporting of thyroid 
cytology. J Endocrinol Invest 2014;37:593-599.
16. Baloch ZW, Cooper DS, Gharib H, Alexander EK. Overview of 
diagnostic terminology and reporting. In: Ali SZ, Cibas E, eds. The 
Bethesda System for Reporting Thyroid Cytopathology: definitions, 
criteria, and explanatory notes. New York: Springer, 2017;1-6.
17. Grani G, Lamartina L, Ascoli V, Bosco D, Biffoni M, Giacomelli L, 
et al. Reducing the number of unnecessary thyroid biopsies while 
improving diagnostic accuracy: toward the "right" TIRADS. J Clin 
Endocrinol Metab 2019;104:95-102.
18. Grani G, Lamartina L, Biffoni M, Giacomelli L, Maranghi M, Falcone 
R, et al. Sonographically estimated risks of malignancy for thyroid 
nodules computed with five standard classification systems: 
changes over time and their relation to malignancy. Thyroid 
2018;28:1190-1197.
19. Ahmed S, Johnson PT, Horton KM, Lai H, Zaheer A, Tsai S, et 
al. Prevalence of unsuspected thyroid nodules in adults on 
contrast enhanced 16- and 64-MDCT of the chest. World J Radiol 
2012;4:311-317.
20. Shetty SK, Maher MM, Hahn PF, Halpern EF, Aquino SL. Significance 
of incidental thyroid lesions detected on CT: correlation among CT, 
sonography, and pathology. AJR Am J Roentgenol 2006;187:1349-
1356.
21. Schmid KW. Histopathology of C cells and medullary thyroid 
carcinoma. Recent Results Cancer Res 2015;204:41-60.
22. Sindoni A, Fama F, Rosano A, Scisca C, Dionigi G, Koch CA, et 
al. Thyroid nodules coexisting with either cystic or solid breast 
nodules: a new clue for this association between nodules coming 
from ultrasonography. Gland Surg 2017;6:630-637.
23. Xiang D, Xie L, Xu Y, Li Z, Hong Y, Wang P. Papillary thyroid 
microcarcinomas located at the middle part of the middle third of 
the thyroid gland correlates with the presence of neck metastasis. 
Surgery 2015;157:526-533.
24. Zeng RC, Li Q, Lin KL, Zhang W, Gao EL, Huang GL, et al. 
Predicting the factors of lateral lymph node metastasis in papillary 
microcarcinoma of the thyroid in eastern China. Clin Transl Oncol 
2012;14:842-847.
